Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Longitudinal Study of Natural History and Functional Status of Patients With Gamma-sarcoglycanopathy (LGMDR5)

NCT06210672 is registered in ClinicalTrials.gov with Atamyo Therapeutics as lead sponsor.

NCT NCT06210672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Longitudinal Study of Natural History and Functional Status of Patients With Gamma-sarcoglycanopathy (LGMDR5)
Lead sponsor
Atamyo Therapeutics
Phase
Observational
Overall status
Withdrawn
Start date
January 10, 2025
Completion date
September 1, 2025
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gamma-sarcoglycanopathy